Keating Financial Advisory Services’s Agilon Health AGL Stock Holding History

Keating Financial Advisory Services’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107	Buy	+1	New	+$65	﹤0.01%	2467

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Keating Financial Advisory Services's AGL Position: Q2 2026 in Review

Keating Financial Advisory Services opened a new position in Agilon Health (AGL) in Q2 2026: 1 share worth $107. The stake represents ﹤0.01% of the portfolio and ranks #2467 among its holdings.

180 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Keating Financial Advisory Services held 1 share of Agilon Health worth $107 as of Q2 2026.
Agilon Health was a new Keating Financial Advisory Services position in Q2 2026.
Agilon Health made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #2467 holding.
180 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.